NKX2-2 and the closely related NKX2-1 are aberrantly activated by chromosomal translocations in T-ALL while in DLBCL NKX2-1 expression is driven by an altered chromatin configuration [61,63]. The gene discussed is NKX2-2; the disease is acute lymphoblastic leukemia.